D-1215-2016 Class II Terminated

Recalled by Medaus, Inc. — Birmingham, AL

FDA drug recall D-1215-2016 was initiated by Medaus, Inc. on May 13, 2016 and is designated Class II. Reason for recall: Lack of Assurance of Sterility The recall status is terminated (terminated Jun 16, 2017). Affected quantity: 20 mL in Vials.

Recall Details

Product Type
Drugs
Report Date
Jul 20, 2016
Initiation Date
May 13, 2016
Termination Date
Jun 16, 2017
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
20 mL in Vials

Product Description

METHYL B12 1000MCG/ML/PYRIDOXINE 100MG W/PRES. (BENZALKONIUM 0.01%), In a) 1ML Vials and b) 10ML Vials, MEDAUS PHARMACY

Reason for Recall

Lack of Assurance of Sterility

Distribution Pattern

U.S. Nationwide, Japan, and New Zealand.

Code Information

a) Lot #: 160222-85, BUD: 07/05/16. b) Lot #: 160222-85, BUD: 07/05/16.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1215-2016
openFDA file date
Oct 23, 2026
Loaded by RegDataLab
Oct 24, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.